Biomerica, Inc. (BMRA) Analysts See $-0.05 EPSMarch 11, 2018 - By marketbeatInvestors sentiment increased to 0.25 in Q3 2017. $49,324 worth of Biomerica, Inc. (NASDAQ:BMRA) shares were bought by CANO FRANCIS. Analysts expect Biomerica, Inc. (NASDAQ:BMRA) to report $-0.05 EPS on April, 13.They anticipate $0.01 EPS change or 25.00 % from last quarter’s $-0.04 EPS. After having $-0.03 EPS previously, Biomerica, Inc.’s analysts see 66.67 % EPS growth. More notable recent Biomerica, Inc. (NASDAQ:BMRA) news were published by: Globenewswire.com which released: “Mexico’s COFEPRIS (Mexico’s equivalent of the FDA) approves Biomerica …” on March 08, 2018, also Quotes.Wsj.com with their article: “Biomerica Inc. BMRA (US: Nasdaq)” published on February 27, 2011, Marketwatch.com published: “Biomerica Inc.” on May 23, 2017.

Source: Wall Street Journal March 11, 2018 01:18 UTC